05 Compliance

The regulatory file for evening primrose oil

Technical document 05 · Reviewed 2026-11-20 · Evening Primrose Oil

On this page
  1. Four checks, not one
  2. The European Union
  3. The United States
  4. Contaminants and the finished dose
  5. The claim boundary
  6. The file a buyer should hold
  7. The compliance checklist

Evening primrose oil is an established food-supplement ingredient in the EU, the United States and the United Kingdom, and the oil itself is the simple part of the file. What each market still has to prove is the route, the contaminant result at the finished dose, the label and the claim. The buyer's regulatory team confirms the route for the destination; this page lists the parts of the file that belong beside the specification.

In one line

The oil has a history of use, but each market still asks four separate questions: permission, contaminant limits, label wording and claim support.

Four checks, not one

A regulatory file answers four questions that are independent of each other. Is the ingredient permitted in the category? Do the contaminants meet the limit at the finished dose? Does the label name the oil and every other ingredient in the product? Is the claim authorised, or at least defensible, in that market?

The ingredient question is usually the easy one for this oil. The other three still need work: the contaminant limit applies to the softgel or blend as sold, the label declares the oil and the shell ingredients, and the claim must sit inside the authorised list. The specification describes the material; the regulatory file shows how it reaches the market.

The European Union

Directive 2002/46/EC sets the framework for food supplements. It harmonises the vitamin and mineral lists only; other substances, including evening primrose oil, are left to national rules, so the member state of sale matters. Evening primrose oil was in food-supplement use before 15 May 1997 and is not a novel food on that basis. Check the current novel-food catalogue for any new extraction or concentration step, because a process change can alter the answer.

Safety rests on Regulation (EC) No 178/2002. The label is governed by Regulation (EU) No 1169/2011, which covers the ingredient list and the allergen statement, while contaminant limits come from Regulation (EU) 2023/915 and claim wording from Regulation (EC) No 1924/2006. For a softgel, the shell ingredients are part of the finished product and must be permitted and declared alongside the oil.

The United Kingdom is not one file. Great Britain applies the retained framework and the GB novel-foods register; Northern Ireland follows the EU regime. The delivery address decides which set applies; record that decision with the order.

The United States

In the United States, evening primrose oil is sold as a dietary ingredient under DSHEA. The finished product is made under the supplement GMPs of 21 CFR 111 and labelled under 21 CFR 101; the firm, not the supplier, is answerable for both. A dietary ingredient introduced after 15 October 1994 carries a 75-day notification duty unless its pre-1994 history takes it out of that class; evening primrose oil has a long US supplement record, and the supplier should name its basis.

FALCPA's major-allergen list — milk, egg, fish, crustacean shellfish, tree nuts, wheat, peanuts, soybeans and sesame — does not include evening primrose. The oil is still a botanical ingredient and the shell a food ingredient, so the label names both. California's Proposition 65 is a warning law rather than a specification limit; a lead result near the ceiling is a reason to check it.

Contaminants and the finished dose

The contaminant limits apply to the product as sold, not to the drum. The oil's contribution is the limit multiplied by its use level, and the rest of the formula adds to it, so calculate on the finished softgel or blend. The table places the catalog limits beside the EU ceilings in force at this review.

Release limits and EU supplement ceilings · evening primrose oil
ParameterEU supplement ceilingRelease limit
Lead (Pb)3.0 mg/kg≤3 mg/kg
Cadmium (Cd)1.0 mg/kg≤1 mg/kg
Mercury (Hg)0.10 mg/kg≤0.1 mg/kg
Arsenic (As)No harmonised maximum≤2 mg/kg
Peroxide valueNot a regulatory maximum≤5.0 meq O₂/kg
Free fatty acidNot a regulatory maximum≤0.50%
MicrobiologySet by the specificationAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent

The EU ceilings are those of Regulation (EU) 2023/915; arsenic has no harmonised maximum for supplements, so a national or customer limit applies. Peroxide value and free fatty acid describe oil quality, not contamination. They have no EU ceiling, so they sit on the certificate and in the stability file as agreed limits; a customer is free to set a tighter number. The microbial criteria are usually the customer's or the member state's, so confirm them.

The claim boundary

Health claims in the EU and the UK fall under Regulation 1924/2006 and, in Great Britain, the GB register. Only permitted wording may appear, and a footnote cannot make an unlisted statement acceptable. As of this review, no authorised claim covers evening primrose oil or GLA; because GLA has no NRV, even a “source of GLA” line needs a legal opinion.

In the US, a dietary supplement may make a structure/function statement when the DSHEA disclaimer accompanies it. Anything that names a disease or a disease-related condition moves the product into drug territory unless a qualified health claim is authorised. The test is the wording on the finished label, not the specification or the certificate.

Across all three markets, the safe ground is the material: how it is made, tested and certified. Disease copy stays out. This site publishes the specification and makes no health claim.

The file a buyer should hold

Documents behind an evening primrose oil food-supplement file
DocumentWhat it provesCommon gap
SpecificationSpecies, process, GLA basis, limits, methodsGLA with no basis
Batch COAThe measured results against the release gatesA result column that copies the specification
Source and allergen statementThe botanical source and the allergen statusA generic statement with no lot
EU route noteThe pre-1997 use or novel-food positionA generic “EU compliant” line
US ingredient noteThe dietary-ingredient and NDI positionNo evidence of pre-1994 use
Contaminant and micro dataThe lot meets the agreed limitsNumbers without methods or limits of quantification
SDS and stability dataHandling, storage and retest periodA shelf life without data

The compliance checklist

  1. Name the species and the process; confirm the GLA basis.
  2. Fix the route for the destination: EU history-of-use or novel-food position, US dietary-ingredient basis, or UK retained rules.
  3. Run the lead, cadmium, mercury, arsenic and microbiology results against the finished-product limits.
  4. Tie the allergen statement to the botanical source and the softgel shell.
  5. Check the label: ingredient names, net quantity, storage condition and the full ingredient list.
  6. Keep claims to the authorised list and out of disease language.
  7. Keep the specification, COA, SDS, stability file and route notes together and dated.

The catalog limits are on the evening primrose oil product page. The certificate lines are on the COA page, the source evidence is on the identity page, the powder route is on the evening primrose oil powder page, and the market frameworks are set out on the EU, US and UK regulatory pages. The analytical methods are indexed under analytical methods, and the release file is described on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation